ICON PLC (ICLR) is a company that provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries. As a leading global provider of clinical research and development services, ICON PLC has a strong track record of helping clients bring innovative therapies to market. In this technical analysis, we will be looking at various indicators and tools to evaluate the performance of ICON PLC's stock.

Technical indicators play a crucial role in assessing the price movement and trend of a stock. One such indicator is the Relative Strength Index (RSI), which measures the speed and change of price movements. A higher RSI indicates overbought conditions, while a lower RSI suggests oversold conditions. By analyzing the RSI of ICON PLC's stock, we can gauge the momentum and strength of its price movement.

ICON PLC (ICLR) Technical Analysis

Learn about ICON PLC (ICLR) technical analysis indicators such as RSI, ADX, MACD, ROC, STOCHRSI, WILLR. Get insights into the stock's performance and trends. Understand the analysis rating for ICON PLC (ICLR) stock.

ICON PLC (ICLR) Technical Analysis: Indicators, RSI, ADX, MACD, ROC, STOCHRSI, WILLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; and clinical research services, including biostatistics, clinical operations, clinical supplies management, covid-19, data management, decentralized & hybrid clinical solutions, endpoint adjudication services, interactive response technologies, investigator payments, medical affairs, medical writing and publishing, pharmacovigilance, and site and patient solutions. The company also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. In addition, it offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON PLC

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	74.47	Sell	9.2%
auto_graphMACD	1.49	Neutral	-15.6%
auto_graphCCI	226.45	Sell	-70.2%
auto_graphADX	62.43	Neutral	-
auto_graphATR	2.76	Buy	-
auto_graphWILLR	-14.20	Sell	-70.2%
auto_graphROC	1,377.74	Neutral	48.9%
auto_graphSTOCHRSI	53.00	Neutral	-77.3%

Buy	1	-87.50%
Hold	4	-50.00%
Sell	3	-62.50%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

ICON PLC (ICLR) Technical Analysis

Keep an eye on ICON PLC

Frequently Asked Questions

What are the technical signals for ICON PLC (ICLR) stock based on the last 30 days?

Take Your Investments to a Whole New Level